Pvg Asset Management Corp Cellectar Biosciences, Inc. Transaction History

Pvg Asset Management Corp

  • $23.4 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$8.2 - $12.4 $1.59 Million - $2.4 Million
-193,510 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$11.8 - $18.2 $2.16 Million - $3.34 Million
183,350 Added 1804.63%
193,510 $2.3 Million
Q1 2021

May 14, 2021
BUY
$15.2 - $25.0 $154,432 - $254,000
10,160 New
10,160 $163,000

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $12.4M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email